Filewrapper

The Most Difficult Definition: Considerations for Defining “Genetically Modified Organism”

A patent applicant is free to act as their own lexicographer in drafting an application and may define terms as they see fit. Should a word not be defined explicitly in the application, the Patent Office will then give the term “the broadest reasonable interpretation according to a person having ordinary skill in the art” […]

Continue Reading →

When Life Hands you Lemons, Make CoQ10

In the Federal Circuit Decision of Soft Gel Technologies, Inc. v. Jarrow Formulas, Inc., the Court found three related Soft-Gel patents invalid for obviousness. The three patents describe a way to dissolve CoQ10 in monoterpenes for enhanced delivery to the body. The patents disclosed two suitable examples, limonene and carvone and derivatives thereof. However, prior […]

Continue Reading →

Federal Circuit Revives Life-Sciences Patent Directed to Law of Nature

On Tuesday, the Federal Circuit revived a life-sciences patent that was invalidated as being directed to a law of nature. The patent involved a method for multiple freeze-thaw cycles in liver cells. In Vitro Technologies designed the method by using previously frozen cells and then pooling the cells that remained viable for re-freezing and thawing […]

Continue Reading →

USPTO Releases New Guidance on Life Sciences Patent-Eligible Subject Matter

The United States Patent and Trademark Office has issued new guidance for Subject Matter Eligibility of Life Sciences patents. A memorandum with the subject “Formulating a Subject Matter Eligibility Rejection and Evaluating the Applicant’s Response to a Subject Matter Eligibility Rejection” was released May 4, 2016. The Memorandum was accompanied by a new set of […]

Continue Reading →

Tracking the Mayo Effect: Study Examines Personalized Medicine Patent Applications after SCOTUS Decision

The US Supreme Court decided Mayo Collaborative Servs. v. Prometheus Labs. in 2012, effectively redefining the scope of patent eligible subject matter, particularly with respect to biotechnology and personalized medicine. Subsequent decisions by the Court in Myriad and Alice have confirmed what many prognosticators had predicted: a wide-spread broadening of the judicially-created exceptions to patent […]

Continue Reading →

White House Calls for Modernization of Biotechnology Regulations

Biotechnological innovation is potentially subject to a variety of governmental regulations. For example, therapeutics for disease treatment or prevention in humans are subject to review and approval by the Food and Drug Administration (FDA). Innovations relating to crops or livestock may be subject to the Department of Agriculture (USDA). However, the regulations promulgated by these governmental agencies are […]

Continue Reading →

2014 World Food Day and Borlaug Dialogue Takes Place in Des Moines Iowa

The 2014 theme for World Food Day was “Family Farming: Feeding the world, caring for the earth.” This event took place during the 2014 Borlaug Dialogue International Symposium held in Des Moines, Iowa. MVS was represented by attorney Scott Johnson to honor the 2014 Laureate, Dr. Sanjaya Rajaram for his work in developing wheat varieties. […]

Continue Reading →

Stay in Touch

Receive the latest news and updates from us and our attorneys.

Sign Up